329 related articles for article (PubMed ID: 33667279)
41. Reduction of periodontal pathogens adhesion by antagonistic strains.
Van Hoogmoed CG; Geertsema-Doornbusch GI; Teughels W; Quirynen M; Busscher HJ; Van der Mei HC
Oral Microbiol Immunol; 2008 Feb; 23(1):43-8. PubMed ID: 18173797
[TBL] [Abstract][Full Text] [Related]
42. Safety assessment of
Hale JDF; Jain R; Wescombe PA; Burton JP; Simon RR; Tagg JR
Benef Microbes; 2022 Feb; 13(1):47-60. PubMed ID: 35098909
[TBL] [Abstract][Full Text] [Related]
43. Multi-Strain Probiotic Supplementation with a Product Containing Human-Native
Cernioglo K; Kalanetra KM; Meier A; Lewis ZT; Underwood MA; Mills DA; Smilowitz JT
Nutrients; 2021 Dec; 13(12):. PubMed ID: 34959944
[No Abstract] [Full Text] [Related]
44. Adjunctive role of Q10 with
Khodaii Z; Mardi S; Mardi P; Natanzi MM
Front Cell Infect Microbiol; 2023; 13():1053230. PubMed ID: 37187472
[TBL] [Abstract][Full Text] [Related]
45.
Begić G; Badovinac IJ; Karleuša L; Kralik K; Cvijanovic Peloza O; Kuiš D; Gobin I
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108414
[TBL] [Abstract][Full Text] [Related]
46. Lactobacillus reuteri AN417 cell-free culture supernatant as a novel antibacterial agent targeting oral pathogenic bacteria.
Yang KM; Kim JS; Kim HS; Kim YY; Oh JK; Jung HW; Park DS; Bae KH
Sci Rep; 2021 Jan; 11(1):1631. PubMed ID: 33452304
[TBL] [Abstract][Full Text] [Related]
47. Probiotics Streptococcus salivarius 24SMB and Streptococcus oralis 89a interfere with biofilm formation of pathogens of the upper respiratory tract.
Bidossi A; De Grandi R; Toscano M; Bottagisio M; De Vecchi E; Gelardi M; Drago L
BMC Infect Dis; 2018 Dec; 18(1):653. PubMed ID: 30545317
[TBL] [Abstract][Full Text] [Related]
48. Lactobacillus reuteri influences regrowth of mutans streptococci after full-mouth disinfection: a double-blind, randomised controlled trial.
Romani Vestman N; Hasslöf P; Keller MK; Granström E; Roos S; Twetman S; Stecksén-Blicks C
Caries Res; 2013; 47(4):338-45. PubMed ID: 23486236
[TBL] [Abstract][Full Text] [Related]
49.
Sulistiowati CP; Suhartono M; Rahmawati DF; Ulfah N; Supandi SK; Wijaksana IKE; Abullais SS; Dhadse P
Front Biosci (Landmark Ed); 2023 May; 28(5):106. PubMed ID: 37258475
[TBL] [Abstract][Full Text] [Related]
50. Effect of Probiotic Lactobacillus salivarius on Peri-Implantitis Pathogenic Bacteria: An In Vitro Study.
Mulla M; Hegde S; Koshy A; Mulla M
Cureus; 2021 Dec; 13(12):e20808. PubMed ID: 35111477
[TBL] [Abstract][Full Text] [Related]
51. Growth inhibition of oral mutans streptococci and candida by commercial probiotic lactobacilli--an in vitro study.
Hasslöf P; Hedberg M; Twetman S; Stecksén-Blicks C
BMC Oral Health; 2010 Jul; 10():18. PubMed ID: 20598145
[TBL] [Abstract][Full Text] [Related]
52. Oral Colonisation after the Administration of Drops Containing Lactobacillus reuteri.
Alforaidi S; Bresin A; Almosa N; Lehrkinder A; Lingström P
Oral Health Prev Dent; 2020 Nov; 18():1017-1023. PubMed ID: 33215493
[TBL] [Abstract][Full Text] [Related]
53. Periodontal pathogens promote cancer aggressivity via TLR/MyD88 triggered activation of Integrin/FAK signaling that is therapeutically reversible by a probiotic bacteriocin.
Kamarajan P; Ateia I; Shin JM; Fenno JC; Le C; Zhan L; Chang A; Darveau R; Kapila YL
PLoS Pathog; 2020 Oct; 16(10):e1008881. PubMed ID: 33002094
[TBL] [Abstract][Full Text] [Related]
54. Mutans streptococci in subgingival plaque of treated and untreated patients with periodontitis.
Van der Reijden WA; Dellemijn-Kippuw N; Stijne-van Nes AM; de Soet JJ; van Winkelhoff AJ
J Clin Periodontol; 2001 Jul; 28(7):686-91. PubMed ID: 11422591
[TBL] [Abstract][Full Text] [Related]
55. Probiotics and periodontal health.
Gupta G
J Med Life; 2011 Nov; 4(4):387-94. PubMed ID: 22514571
[TBL] [Abstract][Full Text] [Related]
56. Inhibitory effect of Lactobacillus salivarius on Streptococcus mutans biofilm formation.
Wu CC; Lin CT; Wu CY; Peng WS; Lee MJ; Tsai YC
Mol Oral Microbiol; 2015 Feb; 30(1):16-26. PubMed ID: 24961744
[TBL] [Abstract][Full Text] [Related]
57. Human-derived probiotic Lactobacillus reuteri demonstrate antimicrobial activities targeting diverse enteric bacterial pathogens.
Spinler JK; Taweechotipatr M; Rognerud CL; Ou CN; Tumwasorn S; Versalovic J
Anaerobe; 2008 Jun; 14(3):166-71. PubMed ID: 18396068
[TBL] [Abstract][Full Text] [Related]
58. The Comparative Evaluation of the Antimicrobial Effect of Propolis with Chlorhexidine against Oral Pathogens: An In Vitro Study.
Akca AE; Akca G; Topçu FT; Macit E; Pikdöken L; Özgen IŞ
Biomed Res Int; 2016; 2016():3627463. PubMed ID: 26949701
[TBL] [Abstract][Full Text] [Related]
59. In vitro Inhibition of Clinical Isolates of Otitis Media Pathogens by the Probiotic Streptococcus salivarius BLIS K12.
Chen TY; Hale JDF; Tagg JR; Jain R; Voss AL; Mills N; Best EJ; Stevenson DS; Bird PA; Walls T
Probiotics Antimicrob Proteins; 2021 Jun; 13(3):734-738. PubMed ID: 33179212
[TBL] [Abstract][Full Text] [Related]
60. Co-aggregation and growth inhibition of probiotic lactobacilli and clinical isolates of mutans streptococci: an in vitro study.
Keller MK; Hasslöf P; Stecksén-Blicks C; Twetman S
Acta Odontol Scand; 2011 Sep; 69(5):263-8. PubMed ID: 21306197
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
